Table 2.
Scoring system developed at the 8th International Meeting on Wilson's disease, Leipzig 2001.33
| Symptoms | |
| Kayser–Fleischer rings | |
| Present | 2 |
| Absent | 0 |
| Neurologic symptoms or typical imaging at brain magnetic resonance imaging | |
| Severe | 2 |
| Mild | 1 |
| Absent | 0 |
| Serum ceruloplasmin | |
| Normal (>0.2 g/L) | 0 |
| 0.1–0.2 g/L | 1 |
| <0.1 g/L | 2 |
| Coombs negative hemolytic anemia | |
| Present | 1 |
| Absent | 0 |
| Other tests | |
| Liver copper (in the absence of cholestasis) | |
| >5x ULN (>4 μmol/g) | 2 |
| 0.8–4 μmol/g | 1 |
| Normal (<0.8 μmol/g) | −1 |
| Rhodanine-positive granulesa | 1 |
| Urinary copper (in the absence of acute hepatitis) | |
| Normal | 0 |
| 1-2x ULN | 1 |
| >2 ULN | 2 |
| Normal, but >5x ULN after D-Penicillamine | 2 |
| Mutation analysis | |
| On both chromosome detected | 4 |
| On 1 chromosome detected | 1 |
| No mutations detected | 0 |
| Total score | Evaluation: |
| 4 or more | Diagnosis established |
| 3 | Diagnosis possible, more tests needed |
| 2 or less | Diagnosis very unlikely |
ULN: upper limit of normal.
If no quantitative liver copper available.
Reproduced with permission from Elsevier Publications J Hepatol. 2012; 56:671–85.